W. Schütte

发表

Bronchial Thermoplasty Including the Middle Lobe Bronchus Significantly Improves Lung Function and Quality of Life in Patients Suffering from Severe Asthma

K. Darwiche, Shaheen Islam, S. Eisenmann, 2019, Lung.

Randomized phase III trial of amrubicin versus topotecan as second-line treatment for patients with small-cell lung cancer.

K. Nackaerts, M. Socinski, F. Shepherd, 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Regulation by transforming growth factor-beta1 of class II mRNA and protein expression in fibroblast-like synoviocytes from patients with rheumatoid arthritis.

A. Kehlen, W. Schütte, J. Langner, 1998, International immunology.

Blood Immune Cell Biomarkers in Patient With Lung Cancer Undergoing Treatment With Checkpoint Blockade

B. Seliger, W. Schütte, D. Riemann, 2019, Journal of immunotherapy.

[Palliative care in respiratory medicine].

C. Eschbach, D. Heigener, C. Bausewein, 2009, Pneumologie.

[Rebiopsy for Patients with Lung Cancer - Joint Opinion from both the Endoscopic and Thoracic Oncology Sections of the German Society of Pneumology (DGP)].

C. Schumann, M. Tiemann, N. Reinmuth, 2018, Pneumologie.

[Hypercapnic failure in patients with COPD under 4 weeks non-invasive, home mechanical ventilation].

C. Criée, S. Schädlich, W. Schütte, 2008, Pneumologie.

[Prognostic Relevance of the Metastatic Localisation in Patients with Stage IV NSCLC - Results of a Prospective Epidemiological Study].

J. Haerting, W. Schütte, T. Blankenburg, 2010, Pneumologie.

[Second-line chemotherapy in non-small-cell lung cancer].

W. Schütte, 2004, Revue de pneumologie clinique.

Regulatory T cells with reduced repressor capacities are extensively amplified in pulmonary sarcoid lesions and sustain granuloma formation.

B. Seliger, A. Schmidt, C. Grohé, 2011, Clinical immunology.

[Cardiac efficiency in patients with Cheyne-Stokes respiration as a result of heart insufficiency during long-term nasal respiratory treatment with adaptive servo ventilation (AutoSet CS)].

S. Schädlich, W. Schütte, T. Blankenburg, 2004, Zeitschrift fur Kardiologie.

Topotecan in the Therapy of Brain Metastases in Lung Cancer

J. von Pawel, C. Manegold, W. Schütte, 1998, Oncology Research and Treatment.

Survival of Hypercapnic Patients with COPD and Obesity Hypoventilation Syndrome Treated with High Intensity Non Invasive Ventilation in the Daily Routine Care

C. Lautenschläger, W. Schütte, T. Blankenburg, 2017, The open respiratory medicine journal.

[Prevention, diagnosis, therapy, and follow-up of lung cancer].

H. Kauczor, I. Petersen, C. Rübe, 2010, Pneumologie.

Topotecan--a new treatment option in the therapy of brain metastases of lung cancer.

J. von Pawel, C. Manegold, W. Schütte, 1999, Frontiers of radiation therapy and oncology.

Pemetrexed in combination with cisplatin or carboplatin as adjuvant chemotherapy in early-stage NSCLC.

J. Mazières, N. Viñolas, M. Reck, 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Clinical Experience of Immunotherapy Treatment: Efficacy and Toxicity Analysis of the Compassionate Use Program of Nivolumab in Patients with Advanced Squamous Cell Non-Small Cell Lung Cancer

F. Griesinger, S. Thiel, W. Schütte, 2019, Oncology Research and Treatment.

Gabapentin potentiation of the antiepileptic efficacy of vigabatrin in an in vitro model of epilepsy

T. Mayer, R. Köhling, E. Speckmann, 1998, British journal of pharmacology.

Blood Immune Cell Biomarkers in Lung Cancer Patients Undergoing Treatment with a Combination of Chemotherapy and Immune Checkpoint Blockade

B. Seliger, A. Wienke, W. Schütte, 2022, Cancers.

Behandlung der respiratorischen Papillomatose – Kasuistik zur systemischen Therapie mit Bevacizumab1

Innere Medizin, G. Thieme, W. Schütte, 2009, Pneumologie.

Prospective, Noninterventional Study of Nivolumab in Real-world Patients With Locally Advanced or Metastatic Non–small Cell Lung Cancer After Prior Chemotherapy (ENLARGE-Lung)

H. Müller-Huesmann, J. Bargon, M. Sebastian, 2021, Journal of immunotherapy.

High PD-L1/CD274 Expression of Monocytes and Blood Dendritic Cells Is a Risk Factor in Lung Cancer Patients Undergoing Treatment with PD1 Inhibitor Therapy

B. Seliger, W. Schütte, D. Riemann, 2020, Cancers.

Efficacy and Safety of Onartuzumab in Combination With First‐Line Bevacizumab‐ or Pemetrexed‐Based Chemotherapy Regimens in Advanced Non‐Squamous Non–Small‐Cell Lung Cancer

H. Wakelee, S. Novello, F. D. De Braud, 2017, Clinical lung cancer.

KRAS G12C-mutated advanced non-small cell lung cancer: A real-world cohort from the German prospective, observational, nation-wide CRISP Registry (AIO-TRK-0315).

W. Weichert, A. Stenzinger, Michael Thomas, 2021, Lung cancer.

Blood immune cell biomarkers in lung cancer

T. Giese, B. Seliger, W. Schütte, 2018, Clinical and experimental immunology.

Lung Cancer in Germany.

U. Nestle, F. Länger, M. Reck, 2022, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Different treatment strategies versus a common standard arm (CSA) in patients with newly diagnosed AML over the age of 60 years: a randomized German inter-group study

W. Hiddemann, B. Dörken, A. Krämer, 2023, Annals of Hematology.

Gabapentin add‐on treatment: how many patients become seizure‐free?: An open‐label multicenter study

C. Elger, T. Mayer, P. Wolf, 1999, Acta neurologica Scandinavica.

Monitoring Blood Immune Cells in Patients with Advanced Small Cell Lung Cancer Undergoing a Combined Immune Checkpoint Inhibitor/Chemotherapy

B. Seliger, W. Schütte, D. Riemann, 2023, Biomolecules.

[Paraneoplastic IgA nephritis as the initial symptom of bronchial carcinoma].

W. Schütte, B. Osten, K. Ohlmann, 1996, Pneumologie.

Ultrafiltration and absorption characteristics of hydroxyethylstarch and dextran during long dwell peritoneal dialysis exchanges in rats.

A. Pustelnik, W. Schütte, G. Gahl, 1989, Advances in peritoneal dialysis. Conference on Peritoneal Dialysis.

Prevention, Diagnosis, Therapy, and Follow-up of Lung Cancer

H. Kauczor, I. Petersen, C. Rübe, 2010, Pneumologie.

Survival of Patients in Clinical Stages I–IIIb of Non-Small-Cell Lung Cancer Treated with Radiation Therapy Alone

Oliver Kuss, Johannes Haerting, J. Haerting, 2004, Strahlentherapie und Onkologie.

Kriterien zur Evaluation des Ansprechens auf Biologika bei schwerem Asthma – der Biologics Asthma Response Score (BARS)

J. Fuge, W. Schütte, K. Milger, 2023, Pneumologie.

Efficacy, safety and predictive biomarker results from OAK, a randomized phase III study comparing atezolizumab with docetaxel in patients with advanced NSCLC

F. Ciardiello, F. Barlesi, M. Ballinger, 2017, Pneumologie.

[Prevention, diagnosis, therapy, and follow-up of lung cancer. Interdisciplinary guideline of the German Respiratory Society and the German Cancer Society--abridged version].

H. Kauczor, I. Petersen, C. Rübe, 2011, Pneumologie.

Phase II trial of docetaxel and carboplatin in the treatment of advanced non-small cell lung cancer

S. Schädlich, B. Wollschläger, W. Schütte, 1997 .

Prognostische Relevanz der Metastasenlokalisation bei nicht kleinzelligem Bronchialkarzinom im Tumorstadium IV – Ergebnisse einer prospektiven epidemiologischen Studie

J. Haerting, W. Schütte, T. Blankenburg, 2010, Pneumologie.

Rekompensation von schwerem hyperkapnischem Versagen bei Patienten mit COPD unter 4 Wochen intermittierender nicht invasiver Heimbeatmung

W. Schütte, D. Roloff, S. Schädlich, 2008, Pneumologie.